{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:48:57Z","timestamp":1792007337118,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-025-03347-x","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:47:37Z","timestamp":1744289257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Blood-brain barrier biomarkers modulate the associations of peripheral immunity with Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Jia-Hui","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1251-6130","authenticated-orcid":false,"given":"Li-Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"3347_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/s0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397:1577\u201390. https:\/\/doi.org\/10.1016\/s0140-6736(20)32205-4","journal-title":"Lancet"},{"key":"3347_CR2","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/s2468-2667(21)00249-8","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators.","year":"2022","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105\u2013e25. https:\/\/doi.org\/10.1016\/s2468-2667(21)00249-8","journal-title":"Lancet Public Health"},{"key":"3347_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:32 https:\/\/doi.org\/10.1186\/s13024-019-0333-5","journal-title":"Mol Neurodegener"},{"key":"3347_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16:358\u201372. https:\/\/doi.org\/10.1038\/nrn3880","journal-title":"Nat Rev Neurosci"},{"key":"3347_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement. 2018;4:575\u201390. https:\/\/doi.org\/10.1016\/j.trci.2018.06.014","journal-title":"Alzheimers Dement"},{"key":"3347_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13195-022-00968-y","volume":"14","author":"JH Hou","year":"2022","unstructured":"Hou JH, Ou YN, Xu W, Zhang PF, Tan L, Yu JT. Association of peripheral immunity with cognition, neuroimaging, and Alzheimer\u2019s pathology. Alzheimers Res Ther. 2022;14:29 https:\/\/doi.org\/10.1186\/s13195-022-00968-y","journal-title":"Alzheimers Res Ther"},{"key":"3347_CR7","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.immuni.2022.10.016","volume":"55","author":"X Chen","year":"2022","unstructured":"Chen X, Holtzman DM. Emerging roles of innate and adaptive immunity in Alzheimer\u2019s disease. Immunity. 2022;55:2236\u201354. https:\/\/doi.org\/10.1016\/j.immuni.2022.10.016","journal-title":"Immunity"},{"key":"3347_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13024-024-00726-8","volume":"19","author":"L van Olst","year":"2024","unstructured":"van Olst L, Kamermans A, Halters S, van der Pol SMA, Rodriguez E, Verberk IMW, et al. Adaptive immune changes associate with clinical progression of Alzheimer\u2019s disease. Mol Neurodegener. 2024;19:38 https:\/\/doi.org\/10.1186\/s13024-024-00726-8","journal-title":"Mol Neurodegener"},{"key":"3347_CR9","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.3390\/ijms24076518","volume":"24","author":"B Twarowski","year":"2023","unstructured":"Twarowski B, Herbet M. Inflammatory processes in Alzheimer\u2019s disease-pathomechanism, diagnosis and treatment: a review. Int J Mol Sci. 2023;24:6518 https:\/\/doi.org\/10.3390\/ijms24076518","journal-title":"Int J Mol Sci"},{"key":"3347_CR10","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20171406","volume":"214","author":"A Montagne","year":"2017","unstructured":"Montagne A, Zhao Z, Zlokovic BV. Alzheimer\u2019s disease: a matter of blood-brain barrier dysfunction? J Exp Med. 2017;214:3151\u201369. https:\/\/doi.org\/10.1084\/jem.20171406","journal-title":"J Exp Med"},{"key":"3347_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133\u201350. https:\/\/doi.org\/10.1038\/nrneurol.2017.188","journal-title":"Nat Rev Neurol"},{"key":"3347_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","volume":"17","author":"BM Bettcher","year":"2021","unstructured":"Bettcher BM, Tansey MG, Doroth\u00e9e G, Heneka MT. Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus. Nat Rev Neurol. 2021;17:689\u2013701. https:\/\/doi.org\/10.1038\/s41582-021-00549-x","journal-title":"Nat Rev Neurol"},{"key":"3347_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nature09513","volume":"468","author":"R Daneman","year":"2010","unstructured":"Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010;468:562\u20136. https:\/\/doi.org\/10.1038\/nature09513","journal-title":"Nature"},{"key":"3347_CR14","doi-asserted-by":"publisher","first-page":"e1005096","DOI":"10.1371\/journal.ppat.1005096","volume":"11","author":"BP Daniels","year":"2015","unstructured":"Daniels BP, Klein RS. Knocking on closed doors: host interferons dynamically regulate blood-brain barrier function during viral infections of the central nervous system. PLoS Pathog. 2015;11:e1005096 https:\/\/doi.org\/10.1371\/journal.ppat.1005096","journal-title":"PLoS Pathog"},{"key":"3347_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11682-012-9176-1","volume":"6","author":"LE Gibbons","year":"2012","unstructured":"Gibbons LE, Carle AC, Mackin RS, Harvey D, Mukherjee S, Insel P, et al. A composite score for executive functioning, validated in Alzheimer\u2019s disease neuroimaging initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging Behav. 2012;6:517\u201327. https:\/\/doi.org\/10.1007\/s11682-012-9176-1","journal-title":"Brain Imaging Behav"},{"key":"3347_CR16","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","volume":"6","author":"PK Crane","year":"2012","unstructured":"Crane PK, Carle A, Gibbons LE, Insel P, Mackin RS, Gross A, et al. Development and assessment of a composite score for memory in the Alzheimer\u2019s disease neuroimaging initiative (ADNI). Brain Imaging Behav. 2012;6:502\u201316. https:\/\/doi.org\/10.1007\/s11682-012-9186-z","journal-title":"Brain Imaging Behav"},{"key":"3347_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","volume":"51","author":"RM Baron","year":"1986","unstructured":"Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173\u201382. https:\/\/doi.org\/10.1037\/0022-3514.51.6.1173","journal-title":"J Pers Soc Psychol"},{"key":"3347_CR18","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet. 2009;41:1094\u20139. https:\/\/doi.org\/10.1038\/ng.439","journal-title":"Nat Genet"},{"key":"3347_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, et al. Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet. 2011;43:429\u201335. https:\/\/doi.org\/10.1038\/ng.803","journal-title":"Nat Genet"},{"key":"3347_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/geno.2000.6472","volume":"72","author":"Y Liang","year":"2001","unstructured":"Liang Y, Tedder TF. Identification of a CD20-, FcepsilonRIbeta-, and HTm4-related gene family: sixteen new MS4A family members expressed in human and mouse. Genomics. 2001;72:119\u201327. https:\/\/doi.org\/10.1006\/geno.2000.6472","journal-title":"Genomics"},{"key":"3347_CR21","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41590-021-00994-2","volume":"22","author":"T Croese","year":"2021","unstructured":"Croese T, Castellani G, Schwartz M. Immune cell compartmentalization for brain surveillance and protection. Nat Immunol. 2021;22:1083\u201392. https:\/\/doi.org\/10.1038\/s41590-021-00994-2","journal-title":"Nat Immunol"},{"key":"3347_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0074-7742(07)82011-3","volume":"82","author":"M Britschgi","year":"2007","unstructured":"Britschgi M, Wyss-Coray T. Systemic and acquired immune responses in Alzheimer\u2019s disease. Int Rev Neurobiol. 2007;82:205\u201333. https:\/\/doi.org\/10.1016\/s0074-7742(07)82011-3","journal-title":"Int Rev Neurobiol"},{"key":"3347_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01155-w","volume":"15","author":"M Jorfi","year":"2023","unstructured":"Jorfi M, Maaser-Hecker A, Tanzi RE. The neuroimmune axis of Alzheimer\u2019s disease. Genome Med. 2023;15:6 https:\/\/doi.org\/10.1186\/s13073-023-01155-w","journal-title":"Genome Med"},{"key":"3347_CR24","doi-asserted-by":"publisher","unstructured":"Qiao M, Ni J, Qing H, Qiu Y, Quan Z. Role of Peripheral NLRP3 Inflammasome in Cognitive Impairments: Insights of Non-central Factors. Mol Neurobiol. 2025. https:\/\/doi.org\/10.1007\/s12035-025-04779-8","DOI":"10.1007\/s12035-025-04779-8"},{"key":"3347_CR25","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.it.2024.08.002","volume":"45","author":"M Schwartz","year":"2024","unstructured":"Schwartz M, Colaiuta SP. Boosting peripheral immunity to fight neurodegeneration in the brain. Trends Immunol. 2024;45:760\u20137. https:\/\/doi.org\/10.1016\/j.it.2024.08.002","journal-title":"Trends Immunol"},{"key":"3347_CR26","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/s41380-022-01446-5","volume":"27","author":"YR Zhang","year":"2022","unstructured":"Zhang YR, Wang JJ, Chen SF, Wang HF, Li YZ, Ou YN, et al. Peripheral immunity is associated with the risk of incident dementia. Mol Psychiatry. 2022;27:1956\u201362. https:\/\/doi.org\/10.1038\/s41380-022-01446-5","journal-title":"Mol Psychiatry"},{"key":"3347_CR27","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.3913","volume":"21","author":"E Zenaro","year":"2015","unstructured":"Zenaro E, Pietronigro E, Della Bianca V, Piacentino G, Marongiu L, Budui S, et al. Neutrophils promote Alzheimer\u2019s disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med. 2015;21:880\u20136. https:\/\/doi.org\/10.1038\/nm.3913","journal-title":"Nat Med"},{"key":"3347_CR28","doi-asserted-by":"publisher","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","volume":"113","author":"SE Marsh","year":"2016","unstructured":"Marsh SE, Abud EM, Lakatos A, Karimzadeh A, Yeung ST, Davtyan H, et al. The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function. Proc Natl Acad Sci USA. 2016;113:E1316\u201325. https:\/\/doi.org\/10.1073\/pnas.1525466113","journal-title":"Proc Natl Acad Sci USA"},{"key":"3347_CR29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3233\/jad-2010-091696","volume":"21","author":"M Saresella","year":"2010","unstructured":"Saresella M, Calabrese E, Marventano I, Piancone F, Gatti A, Calvo MG, et al. PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis. 2010;21:927\u201338. https:\/\/doi.org\/10.3233\/jad-2010-091696","journal-title":"J Alzheimers Dis"},{"key":"3347_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000341583","volume":"34","author":"ME Kuyumcu","year":"2012","unstructured":"Kuyumcu ME, Yesil Y, Ozt\u00fcrk ZA, Kizilarslano\u011flu C, Etg\u00fcl S, Halil M, et al. The evaluation of neutrophil-lymphocyte ratio in Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2012;34:69\u201374. https:\/\/doi.org\/10.1159\/000341583","journal-title":"Dement Geriatr Cogn Disord"},{"key":"3347_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier: from physiology to disease and back. Physiol Rev. 2019;99:21\u201378. https:\/\/doi.org\/10.1152\/physrev.00050.2017","journal-title":"Physiol Rev"},{"key":"3347_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.tins.2022.08.001","volume":"45","author":"HD Mason","year":"2022","unstructured":"Mason HD, McGavern DB. How the immune system shapes neurodegenerative diseases. Trends Neurosci. 2022;45:733\u201348. https:\/\/doi.org\/10.1016\/j.tins.2022.08.001","journal-title":"Trends Neurosci"},{"key":"3347_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40478-021-01253-z","volume":"9","author":"J Xie","year":"2021","unstructured":"Xie J, Gorl\u00e9 N, Vandendriessche C, Van Imschoot G, Van Wonterghem E, Van Cauwenberghe C, et al. Low-grade peripheral inflammation affects brain pathology in the App(NL-G-F)mouse model of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2021;9:163 https:\/\/doi.org\/10.1186\/s40478-021-01253-z","journal-title":"Acta Neuropathol Commun"},{"key":"3347_CR34","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1021\/acschemneuro.9b00333","volume":"10","author":"KA Walker","year":"2019","unstructured":"Walker KA, Ficek BN, Westbrook R. Understanding the role of systemic inflammation in Alzheimer\u2019s disease. ACS Chem Neurosci. 2019;10:3340\u20132. https:\/\/doi.org\/10.1021\/acschemneuro.9b00333","journal-title":"ACS Chem Neurosci"},{"key":"3347_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/imm.12922","volume":"154","author":"J Stephenson","year":"2018","unstructured":"Stephenson J, Nutma E, van der Valk P, Amor S. Inflammation in CNS neurodegenerative diseases. Immunology. 2018;154:204\u201319. https:\/\/doi.org\/10.1111\/imm.12922","journal-title":"Immunology"},{"key":"3347_CR36","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1126\/science.aaa1934","volume":"347","author":"A Zeisel","year":"2015","unstructured":"Zeisel A, Mu\u00f1oz-Manchado AB, Codeluppi S, L\u00f6nnerberg P, La Manno G, Jur\u00e9us A, et al. Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science. 2015;347:1138\u201342. https:\/\/doi.org\/10.1126\/science.aaa1934","journal-title":"Science"},{"key":"3347_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0165-5728(01)00496-9","volume":"124","author":"T Togo","year":"2002","unstructured":"Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, Kato M, et al. Occurrence of T cells in the brain of Alzheimer\u2019s disease and other neurological diseases. J Neuroimmunol. 2002;124:83\u201392. https:\/\/doi.org\/10.1016\/s0165-5728(01)00496-9","journal-title":"J Neuroimmunol"},{"key":"3347_CR38","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41577-021-00508-z","volume":"21","author":"AF Salvador","year":"2021","unstructured":"Salvador AF, de Lima KA, Kipnis J. Neuromodulation by the immune system: a focus on cytokines. Nat Rev Immunol. 2021;21:526\u201341. https:\/\/doi.org\/10.1038\/s41577-021-00508-z","journal-title":"Nat Rev Immunol"},{"key":"3347_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.26134","volume":"90","author":"Z Lin","year":"2021","unstructured":"Lin Z, Sur S, Liu P, Li Y, Jiang D, Hou X, et al. Blood-brain barrier breakdown in relationship to Alzheimer and vascular disease. Ann Neurol. 2021;90:227\u201338. https:\/\/doi.org\/10.1002\/ana.26134","journal-title":"Ann Neurol"},{"key":"3347_CR40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25:270\u20136. https:\/\/doi.org\/10.1038\/s41591-018-0297-y","journal-title":"Nat Med"},{"key":"3347_CR41","doi-asserted-by":"publisher","first-page":"e081635","DOI":"10.1136\/bmjopen-2023-081635","volume":"14","author":"B Padrela","year":"2024","unstructured":"Padrela B, Mahroo A, Tee M, Sneve MH, Moyaert P, Geier O, et al. Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer\u2019s disease (DEBBIE-AD): a prospective observational multicohort study protocol. BMJ Open. 2024;14:e081635 https:\/\/doi.org\/10.1136\/bmjopen-2023-081635","journal-title":"BMJ Open"},{"key":"3347_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581:71\u20136. https:\/\/doi.org\/10.1038\/s41586-020-2247-3","journal-title":"Nature"},{"key":"3347_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11481-006-9025-3","volume":"1","author":"Y Persidsky","year":"2006","unstructured":"Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol. 2006;1:223\u201336. https:\/\/doi.org\/10.1007\/s11481-006-9025-3","journal-title":"J Neuroimmune Pharmacol"},{"key":"3347_CR44","doi-asserted-by":"publisher","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","volume":"316","author":"C Yang","year":"2019","unstructured":"Yang C, Hawkins KE, Dor\u00e9 S, Candelario-Jalil E. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol. 2019;316:C135\u2013c53. https:\/\/doi.org\/10.1152\/ajpcell.00136.2018","journal-title":"Am J Physiol Cell Physiol"},{"key":"3347_CR45","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.4103\/1673-5374.335163","volume":"17","author":"QY Gong","year":"2022","unstructured":"Gong QY, Cai L, Jing Y, Wang W, Yang DX, Chen SW, et al. Urolithin A alleviates blood-brain barrier disruption and attenuates neuronal apoptosis following traumatic brain injury in mice. Neural Regen Res. 2022;17:2007\u201313. https:\/\/doi.org\/10.4103\/1673-5374.335163","journal-title":"Neural Regen Res"},{"key":"3347_CR46","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00401-018-1815-1","volume":"135","author":"S Liebner","year":"2018","unstructured":"Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol. 2018;135:311\u201336. https:\/\/doi.org\/10.1007\/s00401-018-1815-1","journal-title":"Acta Neuropathol"},{"key":"3347_CR47","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.4103\/1673-5374.360250","volume":"18","author":"P Guo","year":"2023","unstructured":"Guo P, Zhang WJ, Lian TH, Zhang WJ, He MY, Zhang YN, et al. Alzheimer\u2019s disease with sleep insufficiency: a cross-sectional study on correlations among clinical characteristics, orexin, its receptors, and the blood-brain barrier. Neural Regen Res. 2023;18:1757\u201362. https:\/\/doi.org\/10.4103\/1673-5374.360250","journal-title":"Neural Regen Res"},{"key":"3347_CR48","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/glia.20478","volume":"55","author":"RK Nuttall","year":"2007","unstructured":"Nuttall RK, Silva C, Hader W, Bar-Or A, Patel KD, Edwards DR, et al. Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia. Glia. 2007;55:516\u201326. https:\/\/doi.org\/10.1002\/glia.20478","journal-title":"Glia"},{"key":"3347_CR49","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E. The cellular phase of Alzheimer\u2019s disease. Cell. 2016;164:603\u201315. https:\/\/doi.org\/10.1016\/j.cell.2015.12.056","journal-title":"Cell"},{"key":"3347_CR50","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","volume":"163","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and dysfunction of the blood-brain barrier. Cell. 2015;163:1064\u201378. https:\/\/doi.org\/10.1016\/j.cell.2015.10.067","journal-title":"Cell"},{"key":"3347_CR51","doi-asserted-by":"publisher","first-page":"576967","DOI":"10.1016\/j.jneuroim.2019.576967","volume":"333","author":"J Shou","year":"2019","unstructured":"Shou J, Peng J, Zhao Z, Huang X, Li H, Li L, et al. CCL26 and CCR3 are associated with the acute inflammatory response in the CNS in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2019;333:576967 https:\/\/doi.org\/10.1016\/j.jneuroim.2019.576967","journal-title":"J Neuroimmunol"},{"key":"3347_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clim.2016.09.010","volume":"189","author":"AK Huber","year":"2018","unstructured":"Huber AK, Giles DA, Segal BM, Irani DN. An emerging role for eotaxins in neurodegenerative disease. Clin Immunol. 2018;189:29\u201333. https:\/\/doi.org\/10.1016\/j.clim.2016.09.010","journal-title":"Clin Immunol"},{"key":"3347_CR53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neurobiolaging.2008.03.024","volume":"31","author":"YJ Liu","year":"2010","unstructured":"Liu YJ, Guo DW, Tian L, Shang DS, Zhao WD, Li B, et al. Peripheral T cells derived from Alzheimer\u2019s disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-alpha-dependent. Neurobiol Aging. 2010;31:175\u201388. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.03.024","journal-title":"Neurobiol Aging"},{"key":"3347_CR54","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.4049\/jimmunol.0904126","volume":"185","author":"T Nakayama","year":"2010","unstructured":"Nakayama T, Watanabe Y, Oiso N, Higuchi T, Shigeta A, Mizuguchi N, et al. Eotaxin-3\/CC chemokine ligand 26 is a functional ligand for CX3CR1. J Immunol. 2010;185:6472\u20139. https:\/\/doi.org\/10.4049\/jimmunol.0904126","journal-title":"J Immunol"},{"key":"3347_CR55","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1084\/jem.185.12.2171","volume":"185","author":"U Forssmann","year":"1997","unstructured":"Forssmann U, Uguccioni M, Loetscher P, Dahinden CA, Langen H, Thelen M, et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med. 1997;185:2171\u20136. https:\/\/doi.org\/10.1084\/jem.185.12.2171","journal-title":"J Exp Med"},{"key":"3347_CR56","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.4049\/jimmunol.169.5.2712","volume":"169","author":"A Menzies-Gow","year":"2002","unstructured":"Menzies-Gow A, Ying S, Sabroe I, Stubbs VL, Soler D, Williams TJ, et al. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol. 2002;169:2712\u20138. https:\/\/doi.org\/10.4049\/jimmunol.169.5.2712","journal-title":"J Immunol"},{"key":"3347_CR57","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1126\/science.277.5334.2005","volume":"277","author":"F Sallusto","year":"1997","unstructured":"Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 1997;277:2005\u20137. https:\/\/doi.org\/10.1126\/science.277.5334.2005","journal-title":"Science"},{"key":"3347_CR58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3988\/jcn.2008.4.2.84","volume":"4","author":"C Choi","year":"2008","unstructured":"Choi C, Jeong JH, Jang JS, Choi K, Lee J, Kwon J, et al. Multiplex analysis of cytokines in the serum and cerebrospinal fluid of patients with Alzheimer\u2019s disease by color-coded bead technology. J Clin Neurol. 2008;4:84\u20138. https:\/\/doi.org\/10.3988\/jcn.2008.4.2.84","journal-title":"J Clin Neurol"},{"key":"3347_CR59","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.jalz.2018.06.2857","volume":"14","author":"GL Bowman","year":"2018","unstructured":"Bowman GL, Dayon L, Kirkland R, Wojcik J, Peyratout G, Severin IC, et al. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults. Alzheimers Dement. 2018;14:1640\u201350. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.2857","journal-title":"Alzheimers Dement"},{"key":"3347_CR60","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.3390\/ijms23084115","volume":"23","author":"HD Ots","year":"2022","unstructured":"Ots HD, Tracz JA, Vinokuroff KE, Musto AE. CD40-CD40L in neurological disease. Int J Mol Sci. 2022;23:4115 https:\/\/doi.org\/10.3390\/ijms23084115","journal-title":"Int J Mol Sci"},{"key":"3347_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0197-4580(01)00246-9","volume":"23","author":"NY Calingasan","year":"2002","unstructured":"Calingasan NY, Erdely HA, Altar CA. Identification of CD40 ligand in Alzheimer\u2019s disease and in animal models of Alzheimer\u2019s disease and brain injury. Neurobiol Aging. 2002;23:31\u20139. https:\/\/doi.org\/10.1016\/s0197-4580(01)00246-9","journal-title":"Neurobiol Aging"},{"key":"3347_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-3-3","volume":"3","author":"V Laporte","year":"2006","unstructured":"Laporte V, Ait-Ghezala G, Volmar CH, Mullan M. CD40 deficiency mitigates Alzheimer\u2019s disease pathology in transgenic mouse models. J Neuroinflammation. 2006;3:3 https:\/\/doi.org\/10.1186\/1742-2094-3-3","journal-title":"J Neuroinflammation"},{"key":"3347_CR63","doi-asserted-by":"publisher","first-page":"e22702","DOI":"10.1096\/fj.202201197R","volume":"37","author":"SH Kim","year":"2023","unstructured":"Kim SH, Lim KH, Yang S, Joo JY. Boosting of tau protein aggregation by CD40 and CD48 gene expression in Alzheimer\u2019s disease. FASEB J. 2023;37:e22702 https:\/\/doi.org\/10.1096\/fj.202201197R","journal-title":"FASEB J"},{"key":"3347_CR64","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/s0197-0186(01)00044-4","volume":"39","author":"T Town","year":"2001","unstructured":"Town T, Tan J, Mullan M. CD40 signaling and Alzheimer\u2019s disease pathogenesis. Neurochem Int. 2001;39:371\u201380. https:\/\/doi.org\/10.1016\/s0197-0186(01)00044-4","journal-title":"Neurochem Int"},{"key":"3347_CR65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2008.10.091","volume":"450","author":"P Buchhave","year":"2009","unstructured":"Buchhave P, Janciauskiene S, Zetterberg H, Blennow K, Minthon L, Hansson O. Elevated plasma levels of soluble CD40 in incipient Alzheimer\u2019s disease. Neurosci Lett. 2009;450:56\u20139. https:\/\/doi.org\/10.1016\/j.neulet.2008.10.091","journal-title":"Neurosci Lett"},{"key":"3347_CR66","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/s0140-6736(14)61403-3","volume":"385","author":"DW Lee","year":"2015","unstructured":"Lee DW, Kochenderfer JN, Stetler-Stevenson M, Cui YK, Delbrook C, Feldman SA, et al. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet. 2015;385:517\u201328. https:\/\/doi.org\/10.1016\/s0140-6736(14)61403-3","journal-title":"Lancet"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03347-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03347-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03347-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:47:37Z","timestamp":1744289257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03347-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3347"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03347-x","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Partners Healthcare Institutional Review Board (IRB), and written informed consent was obtained from all participants prior to initiation of any study procedures in accordance with IRB guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participant"}}],"article-number":"138"}}